Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-23-000026

Options or other derivatives

  • Director disposed of 44,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Litzka Olivier Director 2023-04-27 Other disposition · Stock Option −44,000 0 D: show line 1 in the form
Loading xslF345X04/wf-form4_168297155965134.xml…